Bionime Corporation completed the Taiwan clinical trial and got a Taiwan clinical study report for Continuous Glucose Monitoring System. The Company will prepare the relevant documents to submit the clinical study report of CGM products to TFDA for registration submission and to get product certificate. Afterwards, the Company will start international clinical strategies in planned sites, followed by getting approval in different regions.